Quest for the right Drug
ניטרולינגואל ספריי NITROLINGUAL SPRAY (GLYCERYL TRINITRATE)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
מתחת ללשון : SUBLINGUAL
צורת מינון:
תמיסה : SOLUTION
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Adverse reactions : תופעות לוואי
4.8 Undesirable effects Undesirable effects are listed below by system organ class and frequency. Frequencies are defined as follows: very common ≥1/10 (≥10%); common ≥1/100 and <1/10 (≥1% and <10%); uncommon ≥1/1000 and <1/100 (≥0.1% and <1%); rare ≥1/10,000 and <1/1000 ( ≥0.01% and <0.1%); very rare <1/10,000 (< 0.01%); not known (cannot be estimated from the available data). Blood and lymphatic system disorders Very rare Methaemoglobinaemia Psychiatric disorders Very rare Restlessness Nervous system disorders Headache Very common Dizziness Common Drowsiness Uncommon Syncope Very rare Cerebral ischaemias Cardiac disorders Common Tachycardia Uncommon Enhanced angina pectoris symptoms Bradycardia Cyanosis Vascular disorders Common Orthostatic hypotension* Facial flushing Uncommon Circulatory collapse Gastrointestinal disorders Uncommon Nausea Vomiting Not known Tongue swelling** Tongue blistering Respiratory, thoracic and mediastinal disorders Impairment of respiration Very Rare Skin and subcutaneous tissue disorders Allergic dermatitis** Uncommon Exfoliative dermatitis Very rare Drug rash General disorders and administration site conditions Asthenia Common Investigations Common Blood pressure decreased* *Particularly upon initiation of therapy and following an increase in dose. **Symptoms which are known in conjunction with hypersensitivity reactions Large doses of glyceryl trinitrate may cause vomiting, cyanosis, restlessness, methaemoglobinaemia and impairment of respiration. During treatment with glyceryl trinitrate, temporary hypoxemia may occur due to a relative redistribution of the blood flow in hypoventilated alveolar areas. Reporting suspected adverse reactions after authorization of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Any suspected adverse events should be reported to the Ministry of Health according to the National Regulation by using an online form https://sideeffects.health.gov.il
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
01/01/2000
הגבלות
תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת
מידע נוסף